Medipharm Labs Corp T.LABS

Does the Canadian Federal Gov listen to the experts

[mdjbrown]

in the budget on the April 16, 2023?

“In March, the federal government's expert panel reviewing the Cannabis Act made recommendations in various areas, including medical cannabis.”

“The panel's recommendations address some of the other hurdles Fitzcharles identified, including effectiveness and high cost. The panel is recommending:

• Allowing cannabis product sales in pharmacies to people with medical authorization.
• Removing the excise tax from medical cannabis.
• Supporting clinical guidance documents for health-care professionals on medical use of cannabis.”

https://www.cbc.ca/news/health/second-opinion-medical-cannabis-1.7162603

[mdjbrown]

typo - April 16, 2024?

[QContinuum1]

The idiots are not going to listen.  The best we can hope for is another panel to study I'm afraid. Here's hoping though.

[Starkicker]

I'm optimistic about the how the feds respond to the recommendations. I think they'll drop the excise tax for medical marijuana but only reduce it for recreational. They have to meet producers somewhere in the middle, especially since  it was recommended the 10mg THC limit be kept, which wasn't surprising. Still, I think they'll loosen the noose.

[subaru1i]

mdjbrown...some of those points, especially 1 and 3 apply to pharma appliations imho.  The second bullet point would also benefit LABS as a licensed pharmaceutical site for cannabis.    Cost advantage???????   Preliminary math, as a flower grower that may also produce oils for recreational may have to pay a higer excise tax compared to LABS within the pharma/medical